Eva Engelhardt
Vermogen: 101 589 $ op 30-06-2026
Vermogen: 101 589 $ op 30-06-2026
Ms. Eva A. Engelhardt is an Independent Director at Canatu Oyj and a President-Clinical Diagnostics Group & EVP at Bio-Rad Laboratories, Inc. She is on the Board of Directors at Canatu Oyj.
Ms. Engelhardt was previously employed as a Senior VP-Strategy & Marketing by CEPHEID.
She received her undergraduate degree from Royal Institute of Technology and a graduate degree from Royal Institute of Technology.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-05-2026 | 346 ( 0% ) | 101 589 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BIO-RAD LABORATORIES, INC. | Corporate Officer/Principal | 10-06-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| CEPHEID | Verkoop & Marketing | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes life science research products & clinical diagnostics | Health Technology |
CEPHEID
CEPHEID Medical SpecialtiesHealth Technology Develops, manufactures and markets molecular diagnostic systems | Health Technology |
Royal Institute of Technology
Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau